Terragen Accelerates Ruminant Probiotic Rollout Amid Global Expansion Push

Terragen Holdings Ltd ( (AU:TGH) ) has shared an update.

Terragen reported strong momentum in its Terragen Probiotic for Ruminants (TPR) business, highlighted by a large-scale assessment with Mort & Co at Australia’s largest single-site beef feedlot covering more than 10,000 head, alongside an 87% quarter-on-quarter increase in TPR sales since its April 2025 launch. The company advanced global market access with regulatory trial permits in Canada, ongoing approvals in Brazil and Canada, and negotiations with a global nutrition group for North American manufacturing and distribution, while drought and weak dairy trading conditions weighed on total sales; meanwhile, its Great Land Plus soil product delivered leading tomato yields in commercial trials, companion animal formulations moved into pilot-scale production, and lamb feedlot usage of TPR expanded through confirmed ongoing dosing commitments and new producer-led demonstrations.

The most recent analyst rating on (AU:TGH) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Terragen Holdings Ltd stock, see the AU:TGH Stock Forecast page.

More about Terragen Holdings Ltd

Terragen Holdings Limited is an Australian research, development and commercialisation company focused on biological products for agriculture, including probiotics for ruminant livestock and microbial soil treatments. Its core offerings target productivity and animal health in beef, dairy and horticulture, with growing efforts to expand into companion animals and international markets such as North America and Brazil.

Average Trading Volume: 285,721

Technical Sentiment Signal: Sell

Current Market Cap: A$12.63M

For detailed information about TGH stock, go to TipRanks’ Stock Analysis page.